Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 25 Apr 2006 |
| Genmab, Constitution of the Board of Directors in Genmab and Grant of Warrants to Employees | 25 Apr 2006 |
| Genmab, notification from major shareholder (section 29) from Fidelity International | 18 Apr 2006 |
| Genmab, annual report 2005 | 6 Apr 2006 |
| Genmab, notice convening annual general meeting 25 April 2006 | 5 Apr 2006 |